Blood filters are usually deployed during long-hour surgeries, such as kidney transplantation, and in cases of emergencies. These surgeries are associated with the chances of excessive blood loss, which makes it difficult to make up the blood loss with new blood, especially in case of rare blood groups. Owing to the ample demand, the key players in the blood filter market offer advanced and fully automated blood filters that reduce human interventions. ExThera Medical Corp. offers innovative filters that are invented to trap and remove SARS-CoV-2, the causative agent of COVID-19, from the blood of infected patients. Its Seraph Microbind Affinity Blood Filter or Seraph 100 is an external, single-use medical filter device designed to remove any pathogens, toxins, and other disease-causing contaminants quickly and safely from the blood. The Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) to different devices in April 2020. None of these devices were previously FDA-cleared for this indication, but they were in the latter stages of research and development. Thus, such technological advancements are likely to bring new trends in the Middle East & Africa blood filter market in the coming years.
Countries in the Middle East have also widely affected the socio-economic condition by the COVID-19 pandemic. The challenges posed by the COVID-19 pandemic and the degrading economics would be particularly frightening for the region's fragile and conflict-torn states, such as Iraq, Sudan, South Africa, and Yemen, as they are likely to result in low imports due to disruptions in the global trade, further caused the shortages of medical supplies and other goods in the Middle East and Africa. This factor is also resulting in significant price hikes in the region. The demand for blood filter systems in the pandemic is tending from the outbreak of Covid-19, now the medical devices companies are working on developing strategies to aid in treatment procedure of COVID-19. Further, the adoption of plasma therapy for treating COVID patients is contributing to the blood filter market progress. The UAE was reported to be adopting convalescent plasma (CP) therapy that involves taking antiviral antibodies from the blood of people recovered from the disease and donating them to the critically ill. With antivirals still undergoing human trials, the CP therapy gained huge importance in the region in 2020. In April 2020, medics at Sheikh Khalifa Medical City in Abu Dhabi treated a patient for the first time with the plasma of an Emirati who had recovered from the virus. In the UAE, the CPT was used in Rashid Hospital to treat more than 170 COVID patients with promising results. The use of CPT led to the elevated demand for blood filters and other blood filtration devices to separate the blood components.
Strategic insights for the Middle East and Africa Blood Filter provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 29,338.38 thousand |
Market Size by 2028 | US$ 37,333.72 thousand |
Global CAGR (2021 - 2028) | 3.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
The geographic scope of the Middle East and Africa Blood Filter refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Middle East and Africa Blood Filter Market is valued at US$ 29,338.38 thousand in 2021, it is projected to reach US$ 37,333.72 thousand by 2028.
As per our report Middle East and Africa Blood Filter Market, the market size is valued at US$ 29,338.38 thousand in 2021, projecting it to reach US$ 37,333.72 thousand by 2028. This translates to a CAGR of approximately 3.5% during the forecast period.
The Middle East and Africa Blood Filter Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Blood Filter Market report:
The Middle East and Africa Blood Filter Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Blood Filter Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Blood Filter Market value chain can benefit from the information contained in a comprehensive market report.